Allergan Aesthetics Launches AA Signature: SKIN360 in the US
Key Takeaways
- Allergan Aesthetics launched AA Signature in the United States with SKIN360, a structured, multimodal aesthetic consultation approach focused initially on smoother, more hydrated skin.
- SKIN360 incorporates assessment resources involving SKINVIVE by JUVÉDERM, SkinMedica HA5 Hydra Collagen Hydrator with Vegan Collagen, and BOTOX Cosmetic; the company notes that the safety and efficacy of these products for combined use have not been studied.
- Allergan Aesthetics plans additional AA Signature consultation protocols through 2027 addressing concerns including lift, structure, skin firmness, and facial definition, according to the company.
Allergan Aesthetics has announced the launch of AA Signature, a collection of structured, multimodal consultation approaches designed to support individualized aesthetic treatment planning.
The program debuts with AA Signature: SKIN360, an assessment approach for patients seeking smoother, more hydrated skin. According to the company, the program combines Allergan Medical Institute educational resources with products from the Allergan Aesthetics portfolio.
AA Signature: SKIN360 Brings Multimodal Aesthetic Consultation to US Practices
The company said its research identified demand for more comprehensive aesthetic consultations. In a 2024 online survey of 155 filler patients, 96% reported being at least somewhat interested in a comprehensive assessment. Separate company research found that 8 in 10 patients proceeded with aesthetic treatment after a comprehensive assessment and agreement with their provider on a plan incorporating 2 or more in-office products or procedures.
Allergan Aesthetics plans to introduce additional AA Signature protocols through 2027, with future assessments addressing lift, structure, skin firmness, and facial definition.
“AA Signature represents a new approach to treatment planning, helping HCPs deliver personalized, multimodal assessments backed by Allergan Aesthetics' robust product portfolio,” Nicole Mowad-Nassar, senior vice president, AbbVie, and president, Global Allergan Aesthetics, said in the announcement.
Source
Allergan Aesthetics press release. September 22, 2026.